Priya Shete, MD, MPH

Associate Professor

I am an Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the University of California, San Francisco where my research has focused on improving access to and quality of tuberculosis (TB) care for vulnerable populations. My research has highlighted the central importance of patient and health system barriers to quality of TB care in high burden settings. My portfolio leverages methods in implementation research, social epidemiology, modelling, and health economics that will allow us to better study and understand these barriers to care as well as to provide tools that will allow national TB programs the ability to design and implement interventions that curb these barriers. My research background is enhanced by my experience working with Global TB Programme of the World Health Organization to support countries such as Brazil, South Africa and Viet Nam in developing research agendas and policy translation tools to integrate social determinants and implementation science into their existing TB control programs. I have also served as a public health advisor for USAID with a focus on health system strengthening. I serve as an attending physician on the Pulmonary Consult Service, in the Medical Intensive Care Unit, and in the Department of Public Health Tuberculosis Clinic at Zuckerberg San Francisco General Hospital.
Certificate, 01/2019 - Implementation Science, University of California
2018 - Diversity, Equity, and Inclusion Champion Training, University of California
MPH, 12/2018 - Health Policy and Management, University of California
06/2015 - Pulmonary and Critical Care Medicine Fellowship, University of California
06/2010 - Residency in Internal Medicine, University of California
M.D., 05/2007 - Medicine, Yale University School of Medicine
B.A., 05/2001 - Biophysics, Johns Hopkins University
  1. Chapman LAC, Shukla P, Rodríguez-Barraquer I, Shete PB, León TM, Bibbins-Domingo K, Rutherford GW, Schechter R, Lo NC. Risk factor targeting for vaccine prioritization during the COVID-19 pandemic. 2022. PMID: 35197495

  2. Nalugwa T, Handley M, Shete P, Ojok C, Nantale M, Reza T, Katamba A, Cattamanchi A, Ackerman S. Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda. 2022. PMID: 35109936

  3. Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The health and economic benefits of tests that predict future progression to tuberculosis disease. 2021. PMID: 34669631

  4. Cattamanchi A, Reza TF, Nalugwa T, Adams K, Nantale M, Oyuku D, Nabwire S, Babirye D, Turyahabwe S, Tucker A, Sohn H, Ferguson O, Thompson R, Shete PB, Handley MA, Ackerman S, Joloba M, Moore DAJ, Davis JL, Dowdy DW, Fielding K, Katamba A. Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. 2021. PMID: 34936740

  5. Thakur N, Lovinsky-Desir S, Appell D, Bime C, Castro L, Celedón JC, Ferreira J, George M, Mageto Y, Mainous Iii AG, Pakhale S, Riekert KA, Roman J, Ruvalcaba E, Sharma S, Shete P, Wisnivesky JP, Holguin F. Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement. 2021. PMID: 34347574

  6. Samuels THA, Shete PB, Ojok C, Nalugwa T, Farr K, Turyahabwe S, Katamba A, Cattamanchi A, Moore DAJ. Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda. 2021. PMID: 34270582

  7. Reitsma MB, Claypool AL, Vargo J, Shete PB, McCorvie R, Wheeler WH, Rocha DA, Myers JF, Murray EL, Bregman B, Dominguez DM, Nguyen AD, Porse C, Fritz CL, Jain S, Watt JP, Salomon JA, Goldhaber-Fiebert JD. Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California. 2021. PMID: 33979192

  8. Mirzazadeh A, Kahn JG, Haddad MB, Hill AN, Marks SM, Readhead A, Barry PM, Flood J, Mermin JH, Shete PB. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. 2021. PMID: 33793612

  9. Tucker A, Oyuku D, Nalugwa T, Nantale M, Ferguson O, Farr K, Reza TF, Shete PB, Cattamanchi A, Dowdy DW, Sohn H, Katamba A. Costs along the TB diagnostic pathway in Uganda. 2021. PMID: 33384046

  10. Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. 2020. PMID: 32916062

  11. Kadota JL, Reza TF, Nalugwa T, Kityamuwesi A, Nanyunja G, Kiwanuka N, Shete P, Davis JL, Dowdy D, Turyahabwe S, Katamba A, Cattamanchi A. Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic. 2020. PMID: 33172531

  12. Rupani MP, Cattamanchi A, Shete PB, Vollmer WM, Basu S, Dave JD. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India. 2020. PMID: 33076969

  13. Akl EA, Blazic I, Yaacoub S, Frija G, Chou R, Appiah JA, Fatehi M, Flor N, Hitti E, Jafri H, Jin ZY, Kauczor HU, Kawooya M, Kazerooni EA, Ko JP, Mahfouz R, Muglia V, Nyabanda R, Sanchez M, Shete PB, Ulla M, Zheng C, van Deventer E, Perez MDR. Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide. 2020. PMID: 32729811

  14. Chimoyi LA, Lienhardt C, Moodley N, Shete P, Churchyard GJ, Charalambous S. Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review. 2020. PMID: 32636313

  15. Parriott A, Kahn JG, Ashki H, Readhead A, Barry PM, Goodell AJ, Flood J, Shete PB. Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. 2020. PMID: 32735191

  16. Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. 2020. PMID: 32735183

  17. Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, Auyeung V, Cattamanchi A, Hendrickson CM. Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series. 2020. PMID: 32511538

  18. Reza TF, Nalugwa T, Farr K, Nantale M, Oyuku D, Nakaweesa A, Musinguzi J, Vangala M, Shete PB, Tucker A, Ferguson O, Fielding K, Sohn H, Dowdy D, Moore DAJ, Davis JL, Ackerman SL, Handley MA, Katamba A, Cattamanchi A. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB). 2020. PMID: 32316993

  19. Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, Mugabe F, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Cattamanchi A, Katamba A. Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective. 2020. PMID: 32131814

  20. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. 2019. PMID: 31626560

  21. Cattamanchi A, Berger CA, Shete PB, Turyahabwe S, Joloba M, Moore DA, Davis LJ, Katamba A. Implementation science to improve the quality of tuberculosis diagnostic services in Uganda. 2019. PMID: 31879703

  22. Babirye D, Shete PB, Farr K, Nalugwa T, Ojok C, Nantale M, Oyuku D, Ayakaka I, Katamba A, Davis JL, Nadunga D, Joloba M, Moore D, Cattamanchi A. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. 2019. PMID: 31720434

  23. Gomes MGM, Oliveira JF, Bertolde A, Ayabina D, Nguyen TA, Maciel EL, Duarte R, Nguyen BH, Shete PB, Lienhardt C. Introducing risk inequality metrics in tuberculosis policy development. Volume 10 of Issue 1. 2019. PMID: 31171791

  24. Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. 2019. PMID: 31151255

  25. Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, Shete PB, Han AH, Fielding K, Joloba M, Mugabe F, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up. 2019. PMID: 31720425

  26. Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for tuberculosis elimination in California: An individual-based stochastic model. 2019. PMID: 30964878

  27. Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. 2019. PMID: 30904263

  28. Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. 2019. PMID: 30890135

  29. Reis-Santos B, Shete P, Bertolde A, Sales CM, Sanchez MN, Arakaki-Sanchez D, Andrade KB, Gomes MGM, Boccia D, Lienhardt C, Maciel EL. Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates. Volume 14 of Issue 2. 2019. PMID: 30794615

  30. Oliosi JGN, Reis-Santos B, Locatelli RL, Sales CMM, da Silva Filho WG, da Silva KC, Sanchez MN, de Andrade KVF, de Araújo GS, Shete PB, Pereira SM, Riley LW, Lienhardt C, Maciel ELN. Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study. Volume 7 of Issue 2. 2018. PMID: 30584050

  31. Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C. Defining a migrant-inclusive tuberculosis research agenda to end TB. Volume 22 of Issue 8. 2018. PMID: 29991390

  32. Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, Sanchez M, Maciel E, Rasella D, Shete P, Pedrazzoli D, Houben R, Chang S, Dowdy D. Modelling the impact of social protection on tuberculosis: the S-PROTECT project. Volume 18 of Issue 1. 2018. PMID: 29940906

  33. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. 2018. PMID: 29663958

  34. Shete PB, Dowdy DW. Measuring success: The challenge of social protection in helping eliminate tuberculosis. Volume 14 of Issue 11. 2017. PMID: 29112688

  35. Sismanidis C, Shete PB, Lienhardt C, Floyd K, Raviglione M. Harnessing the Power of Data to Guide Local Action and End Tuberculosis. Volume 216 of Issue suppl_7. 2017. PMID: 29117345

  36. Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L, Khan IH, Cattamanchi A. Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda. Volume 12 of Issue 8. 2017. PMID: 28767658

  37. Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy. 2017. PMID: 28633698

  38. Shete PB, Haguma P, Miller CR, Ochom E, Ayakaka I, Davis JL, Dowdy DW, Hopewell P, Katamba A, Cattamanchi A. Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda. 2015. PMID: 26162356

  39. Satyanarayana S, Subbaraman R, Shete P, Gore G, Das J, Cattamanchi A, Mayer K, Menzies D, Harries AD, Hopewell P, Pai M. Quality of tuberculosis care in India: a systematic review. 2015. PMID: 26056098

  40. Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. Volume 18 of Issue 5. 2007. PMID: 17854732

  41. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Volume 32 of Issue 1-2. 2006. PMID: 16858776

  42. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Volume 30 of Issue 4. 2005. PMID: 16188453

  43. Cohen NJ, Lauderdale DS, Shete PB, Seal JB, Daum RS. Physician knowledge of catch-up regimens and contraindications for childhood immunizations. Volume 111 of Issue 5 Pt 1. 2003. PMID: 12728067

  44. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Volume 29 of Issue 11. 2002. PMID: 12438901

  45. Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. Volume 186 of Issue 5. 2002. PMID: 12195353